🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/04/2018 6,90 7,00 6,60 6,69 -2,48% 5,80% 1.218.300
02/04/2018 7,19 7,27 6,67 6,86 -4,85% 8,34% 1.545.600
29/03/2018 6,75 7,33 6,63 7,21 +7,29% 10,30% 1.564.400
28/03/2018 6,92 7,07 6,56 6,72 -2,75% 7,30% 1.838.100
27/03/2018 7,30 8,09 6,87 6,91 -0,43% 16,71% 4.395.900
26/03/2018 6,83 7,03 6,52 6,94 +2,81% 7,39% 1.376.200
23/03/2018 6,95 7,08 6,71 6,75 -2,32% 5,31% 987.000
22/03/2018 7,18 7,39 6,91 6,91 -5,60% 6,69% 1.059.300
21/03/2018 7,15 7,38 7,06 7,32 +1,81% 4,48% 1.001.000
20/03/2018 7,24 7,35 7,11 7,19 +0,28% 3,31% 802.000
19/03/2018 7,53 7,55 7,04 7,17 -4,78% 6,77% 1.411.200
16/03/2018 7,45 7,58 7,27 7,53 -0,53% 4,16% 5.068.300
15/03/2018 7,42 7,57 7,31 7,57 +2,71% 3,50% 1.302.200
14/03/2018 7,70 7,79 7,25 7,37 -3,53% 7,01% 1.425.900
13/03/2018 7,53 7,77 7,28 7,64 +1,33% 6,51% 1.857.600
12/03/2018 7,42 7,93 7,36 7,54 +1,75% 7,67% 1.997.500
09/03/2018 7,40 7,45 7,21 7,41 +0,95% 3,24% 844.200
08/03/2018 7,44 7,51 7,21 7,34 -0,68% 4,02% 1.141.900
07/03/2018 7,45 7,60 7,18 7,39 -0,94% 5,64% 1.378.200
06/03/2018 7,39 7,80 7,37 7,46 +2,47% 5,82% 2.095.500
05/03/2018 6,62 7,65 6,61 7,28 +9,31% 15,71% 3.762.500
02/03/2018 6,13 6,67 6,12 6,66 +6,05% 8,89% 1.226.600
01/03/2018 6,47 6,66 6,16 6,28 -3,09% 7,73% 1.592.100
28/02/2018 6,53 6,64 6,38 6,48 +0,47% 3,98% 1.537.500
27/02/2018 6,62 6,80 6,33 6,45 -1,68% 7,10% 2.027.800
26/02/2018 5,86 6,68 5,86 6,56 +13,10% 13,99% 2.535.100
23/02/2018 5,61 5,81 5,35 5,80 +4,69% 8,16% 955.300
22/02/2018 5,63 5,74 5,50 5,54 +0,00% 4,26% 638.900
21/02/2018 5,65 5,81 5,53 5,54 -1,95% 4,96% 741.600
20/02/2018 5,48 5,83 5,48 5,65 +1,44% 6,39% 794.500